11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression.

      The American Journal of Psychiatry

      Adult, Amitriptyline, therapeutic use, Amoxapine, Clinical Trials as Topic, Delusions, drug therapy, psychology, Depressive Disorder, Dibenzoxazepines, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Perphenazine, Psychiatric Status Rating Scales

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In a double-blind study lasting for 4 weeks, the authors compared the effectiveness of amoxapine, an antidepressant with potential antipsychotic properties, with a combination of amitriptyline plus perphenazine in the treatment of 38 patients who had the diagnosis of major depression with psychotic features (psychotic or delusional depression). Patients in each group showed similar improvement in depression and psychosis. There was a tendency for the patients treated with amitriptyline plus perphenazine to have higher global response rates. However, the patients given amoxapine had significantly fewer extrapyramidal side effects.

          Related collections

          Author and article information

          Journal
          2201223

          Comments

          Comment on this article